New research from Karolinska Institutet in Sweden highlights the possibility of screening people with type 2 diabetes for ...

About AEYE Health: AEYE Health is a healthcare technology leader specializing in AI-powered retinal diagnostics. The ...

Diabetic retinopathy screening with AI was associated with higher referral rates to optical coherence tomography but remains underutilized.

Diabetes affects millions worldwide, and while it's primarily known for disrupting blood sugar regulation, its impact extends ...

Oculis' OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says Hong Kong could be one of the first jurisdictions to use a novel ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

Jefferies has upgraded Kodiak Sciences Inc. (NASDAQ:KOD), a biopharmaceutical company focused on retinal (eye) diseases.

New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye disease.

Roche's Vabysmo® (faricimab) prefilled syringe has received European Medicines Agency approval for treating three major ...

Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to curr ...

Tamil Nadu launches new mobile eye units for doorstep screenings, aiming to reduce blindness rates in rural areas.

Landmark publication in leading ophthalmology research journal demonstrates the power of 4DMT’s Therapeutic Vector Evolution platform to invent ...